Skip to main content
Menu
US
Cell Counting and Image Cytometry

High-throughput Neutralization Assay of AAV-GFP Vectors Using Neutralizing Antibodies

Section
Cell-based Assays for Gene Therapy Development
Celigo Applications
Cell Counting Method Selection
Cell Counting and Image Cytometry FAQs
Cell-based Assays for Bioprocessing
Cell-based Assays for Gene Therapy Development
Cellometer Applications
Modern Virology Assays
Sub Section
Neutralizing Antibody Screening
AAV Vector Design
AAV Vector Transduction Efficiencies
FDA Approval for Gene Therapy
Neutralizing Antibody Screening
Topic
High-throughput Neutralization Assay of AAV-GFP Vectors Using Neutralizing Antibodies
High-throughput Neutralization Assay of AAV-GFP Vectors Using Neutralizing Antibodies
High-throughput Neutralization Assay of AAV-GFP Vectors Using Sera

In this experiment, the Celigo™ image cytometer simultaneously imaged and quantified GFP expression after target cells were treated with different concentrations of nAbs.

  1. The target cells were seeded in a 96-well plate and allowed to adhere overnight
  2. Cells were transduced with AAV-A vector to low Multiplicity of Infection (MOI)
  3. Cells were pre-incubated overnight with different dilutions of nAbs and sera at 1X and 5X dilutions
  4. The Celigo was used to image and analyze the cells in brightfield and GFP fluorescence to determine transduction efficiencies

Antibody samples exerted dose-dependent neutralization effects on transduction efficiencies

The Celigo was able to directly measure the GFP+ cell percentages in the presence or absence of different concentrations of nAbs. The GFP fluorescent images and analysis results are shown in Figure 1 and Figure 2 respectively. From the GFP images, the Celigo automatically segments individual cells, allowing rapid quantification of the GFP+ percentage of total cells when compared to brightfield. 

  • The GFP fluorescent images clearly showed that 1X diluted nAb samples dramatically reduced GFP+ percentages (<1%)4
  • The graph confirms that the percentage of GFP-expressing cells was slightly higher for the 5X dilution (~18% of cells)
  • GFP+ percentages were comparable between the nAb and sera at both 1X and 5X dilutions
high throughput neutralization assay of aav gfp vectors using neutralizing antibodies

Figure 1. GFP fluorescent images for nAb treatment at 1X and 5X dilutions.

percentage of target cells treated with nab and sera

Figure 2. GFP+ percentage of target cells treated with nAb and sera at 1X and 5X dilutions demonstrating close-dependent transduction efficiencies

For research use only. Not for use in diagnostic procedures.

ON THIS PAGE